<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">lvrach</journal-id><journal-title-group><journal-title xml:lang="ru">Лечащий Врач</journal-title><trans-title-group xml:lang="en"><trans-title>Lechaschi Vrach</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-5175</issn><issn pub-type="epub">2687-1181</issn><publisher><publisher-name>ООО «Издательство "Открытые системы"»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.51793/OS.2021.24.12.009</article-id><article-id custom-type="elpub" pub-id-type="custom">lvrach-862</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКТУАЛЬНАЯ ТЕМА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>TOPICAL THEME</subject></subj-group></article-categories><title-group><article-title>Саркопения и нутритивная поддержка больных пожилого и старческого  возраста</article-title><trans-title-group xml:lang="en"><trans-title>Sarcopenia and nutritional support for elderly and senile patients</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новикова Татьяна Валериановна - медицинский менеджер, Медицинский Департамент ООО «Нутриция».</p><p>143500, Истра, ул. Московская, 48.</p></bio><bio xml:lang="en"><p>Tatiana V. Novikova - Medical Manager, Medical Department, Nutricia LLC.</p><p>48 Moskovskaya str., Istra, 143500.</p></bio><email xlink:type="simple">tatyana.novikova@danone.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8121-4160</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пасечник</surname><given-names>И. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Pasechnik</surname><given-names>I. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Пасечник Игорь Николаевич – доктор медицинских наук, профессор, заведующий кафедрой анестезиологии и реаниматологии ЦГМА УДП РФ.</p><p>121359, Москва, ул. Маршала Тимошенко, 19, стр. 1А.</p></bio><bio xml:lang="en"><p>Igor N. Pasechnik - Dr. of Sci. (Med.), Professor, Head of department of Anesthesiology and Intensive Care of the Central State Medical Academy of the Administrative Department of the President of the Russian Federation.</p><p>19 b.1A Marshal Timoshenko str., Moscow, 121359.</p></bio><email xlink:type="simple">pasigor@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рыбинцев</surname><given-names>В. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Rybintsev</surname><given-names>V. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рыбинцев Владимир Юрьевич – кандидат медицинских наук, доцент кафедры анестезиологии и реаниматологии ЦГМА УДП РФ.</p><p>121359, Москва, ул. Маршала Тимошенко, 19, стр. 1А.</p></bio><bio xml:lang="en"><p>Vladimir Yu. Rybintsev - MD, Associate Professor of the department of Anesthesiology and Intensive Care of the Central State Medical Academy of the Administrative Department of the President of the Russian Federation.</p><p>19 b.1A Marshal Timoshenko str., Moscow, 121359.</p></bio><email xlink:type="simple">xxxvlad66@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ООО «Нутриция»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Nutricia LLC</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Центральная государственная медицинская академия Управления делами Президента Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Central State Medical Academy of the Administrative Department of the President of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>15</day><month>01</month><year>2022</year></pub-date><volume>0</volume><issue>12</issue><fpage>62</fpage><lpage>66</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Новикова Т.В., Пасечник И.Н., Рыбинцев В.Ю., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Новикова Т.В., Пасечник И.Н., Рыбинцев В.Ю.</copyright-holder><copyright-holder xml:lang="en">Novikova T.N., Pasechnik I.N., Rybintsev V.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.lvrach.ru/jour/article/view/862">https://journal.lvrach.ru/jour/article/view/862</self-uri><abstract><p>Демографическое старение населения приводит к значительному увеличению доли лиц пожилого и старческого возраста как на амбулаторном, так и стационарном этапах лечения. За последнее десятилетие средний возраст основного контингента больных в отделениях реанимации и интенсивной терапии составляет более 65 лет, с тенденцией к увеличению, что предопределяет стратегию более тщательной оценки подходов к проведению лечебных мероприятий с учетом полиморбидности и функциональных возможностей пациентов старших возрастных групп как в период пребывания в стационаре, так и на дальнейших этапах восстановления и реабилитации. Известно, что в целом длительность пребывания в отделениях интенсивной терапии пожилых пациентов значительно выше, а результаты лечения и реабилитации достоверно ниже, чем у более молодых. Это связано с сочетанием целого ряда факторов: коморбидности/ полиморбидности пациентов пожилого и старческого возраста, снижения функциональных резервов организма, синдрома старческой астении, главными составляющими которого являются саркопения, недостаточность питания. Связь старческой астении с увеличением длительности госпитализации, снижением физической активности, развитием функциональных дефицитов, увеличением риска падений, переломов и смертности достаточно хорошо изучена, однако в рутинной клинической практике оценке нутритивного статуса, диагностике недостаточности питания и решению проблемы недостаточности питания пациентов с синдромом старческой астении и саркопении уделяется недостаточное внимание, несмотря на известные факты о взаимосвязи недостаточности питания, снижения массы скелетных мышц, в том числе их силы или функции с неблагоприятным исходами заболевания. В амбулаторном этапе, кроме малоподвижного образа жизни, развитию и прогрессированию саркопении часто способствуют наличие тяжелого заболевания, сопровождающегося системным воспалением, метаболическая резистентность, нутритивная недостаточность и депрессия, характерные для данной категории больных. Современные подходы к лечению пациента пожилого и старческого возраста подразумевают проведение регулярной оценки нутритивного статуса и консультирование по вопросам рационального питания с внедрением методов нутритивной поддержки в комплексную программу ведения пожилого пациента наряду с основными лечебными и реабилитационными мероприятиями с целью замедления прогрессирования синдрома астении и саркопении.</p></abstract><trans-abstract xml:lang="en"><p>Demographic aging of the population leads to a significant increase in the proportion of elderly and senile people, both at the outpatient and inpatient stages of treatment. Over the past decade, the average age of the main contingent of patients in intensive care and intensive care units is more than 65 years, with a tendency to increase, which predetermines the strategy for a more thorough assessment of approaches to treatment measures, taking into account polymorbidity and functional capabilities of patients of older age groups, as the period of stay in hospital, and at further stages of recovery and rehabilitation. It is known that, in general, the duration of stay in intensive care units for elderly patients is much longer, and the results of treatment and rehabilitation are significantly lower than that of younger patients. This is due to a combination of a number of factors: comorbidity/polymorbidity of elderly and senile patients, decreased functional reserves of the body, senile asthenia syndrome, the main components of which are sarcopenia, and malnutrition. The relationship of senile asthenia with an increase in the duration of hospitalization, a decrease in physical activity, the development of functional deficits, an increase in the risk of falls, fractures and mortality is well understood, however, in routine clinical practice, assessing nutritional status, diagnosing malnutrition and solving the problem of malnutrition in patients with senile asthenia syndrome and Insufficient attention is paid to sarcopenia, despite the known facts about the relationship of malnutrition, a decrease in skeletal muscle mass, including their strength or function, with unfavorable outcomes of the disease. In the outpatient phase, in addition to a sedentary lifestyle, the development and progression of sarcopenia is often facilitated by the presence of a severe illness accompanied by systemic inflammation, metabolic resistance, nutritional deficiency and depression characteristic of this category of patients. Modern approaches to the treatment of an elderly and senile patient imply a regular assessment of the nutritional status and counseling on rational nutrition with the introduction of nutritional support methods into a comprehensive management program for an elderly patient, along with basic treatment and rehabilitation measures in order to slow the progression of asthenia and sarcopenia syndrome.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пожилой и старческий возраст</kwd><kwd>саркопения</kwd><kwd>нутритивная недостаточность</kwd></kwd-group><kwd-group xml:lang="en"><kwd>elderly and senile age</kwd><kwd>sarcopenia</kwd><kwd>nutritional deficiency</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Статья подготовлена при участии компании ООО «Нутриция». Это никак не повлияло на мнение авторов.</funding-statement><funding-statement xml:lang="en">The article was prepared with the participation of Nutricia LLC. This did not affect the author's opinion in any way.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Scherbov S., Sanderson W. C. New approaches to the conceptualization and measurement of age and aging // J Aging Health. 2016; 28: 1159-1177. DOI: 10.1177/0898264316656517.</mixed-citation><mixed-citation xml:lang="en">Scherbov S., Sanderson W. C. New approaches to the conceptualization and measurement of age and aging // J Aging Health. 2016; 28: 1159-1177. DOI: 10.1177/0898264316656517.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Flaatten H., de Lange D. W., Artigas A., et al. The status of intensive care medicine research and a future agenda for very old patients in the ICU // Intensive Care Med. 2017; 43 (9): 1319-1328.</mixed-citation><mixed-citation xml:lang="en">Flaatten H., de Lange D. W., Artigas A., et al. The status of intensive care medicine research and a future agenda for very old patients in the ICU // Intensive Care Med. 2017; 43 (9): 1319-1328.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Оганов Р. Г., Драпкина О. М. Полиморбидность: закономерности формирования и принципы сочетания нескольких заболеваний у одного пациента // Кардиоваскулярная терапия и профилактика. 2016; 15 (4): 4-9. DOI: 10.15829/1728-8800-2016-4-4-9.</mixed-citation><mixed-citation xml:lang="en">Oganov R.G., Drapkina O.M. Polymorbidity: patterns of formation and principles of combination of several diseases in one patient. Kardiovaskulyarnaya terapiya i profilaktika, 2016; 15(4): 4-9. DOI: 10.15829/1728-8800-2016-4-4-9.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lefèvre T., d'Ivernois J.-F., De Andrade V. et al. What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization // Rev Epidemiol Sante Publique. 2014; 62 (5): 305-314. DOI: 10.1016/j.respe.2014.09.002.</mixed-citation><mixed-citation xml:lang="en">Lefèvre T., d'Ivernois J.-F., De Andrade V. et al. What do we mean by multimorbidity? An analysis of the literature on multimorbidity measures, associated factors, and impact on health services organization // Rev Epidemiol Sante Publique. 2014; 62 (5): 305-314. DOI: 10.1016/j.respe.2014.09.002.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Paul J. A., Whittington R. A., Baldwin M. R. Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets // Anesth Analg. 2020; 130 (6): 1545-1555. DOI: 10.1213/ANE.0000000000004792.</mixed-citation><mixed-citation xml:lang="en">Paul J. A., Whittington R. A., Baldwin M. R. Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets // Anesth Analg. 2020; 130 (6): 1545-1555. DOI: 10.1213/ANE.0000000000004792.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Montgomery C. L., Rolfson D. B., Bagshaw S. B. Frailty and the Association Between Long-Term Recovery After Intensive Care Unit Admission // Crit Care Clin. 2018; 34 (4): 527-547. DOI: 10.1016/j.ccc.2018.06.007.</mixed-citation><mixed-citation xml:lang="en">Montgomery C. L., Rolfson D. B., Bagshaw S. B. Frailty and the Association Between Long-Term Recovery After Intensive Care Unit Admission // Crit Care Clin. 2018; 34 (4): 527-547. DOI: 10.1016/j.ccc.2018.06.007.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Agostini J. V., Han L., Tinetti M. E. The relationship between number of medications and weight loss or impaired balance in older adults // J Am Geriatr Soc. 2004; 52 (10): 1719-1723. DOI: 10.1111/j.1532-5415.2004.52467.x.</mixed-citation><mixed-citation xml:lang="en">Agostini J. V., Han L., Tinetti M. E. The relationship between number of medications and weight loss or impaired balance in older adults // J Am Geriatr Soc. 2004; 52 (10): 1719-1723. DOI: 10.1111/j.1532-5415.2004.52467.x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Xue Q., Wu J., Ren Y. et al. Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease: a systematic review and meta-analysis // BMC Geriatrics. 2021; 21: 493. DOI: 10.1186/s12877-021-02438-w.</mixed-citation><mixed-citation xml:lang="en">Xue Q., Wu J., Ren Y. et al. Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease: a systematic review and meta-analysis // BMC Geriatrics. 2021; 21: 493. DOI: 10.1186/s12877-021-02438-w.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenberg I. H. Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19-21, 1988 // Am J Clin Nutr. 1989; 50 (5 Suppl): 1121-1235.</mixed-citation><mixed-citation xml:lang="en">Rosenberg I. H. Epidemiologic and methodologic problems in determining nutritional status of older persons. Proceedings of a conference. Albuquerque, New Mexico, October 19-21, 1988 // Am J Clin Nutr. 1989; 50 (5 Suppl): 1121-1235.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz-Jentoft A. J., Baeyens J. P., Bauer J. M., et al. Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People // Age Ageing. 2010; 39 (4): 412-423. DOI: 10.1093/ageing/afq034.</mixed-citation><mixed-citation xml:lang="en">Cruz-Jentoft A. J., Baeyens J. P., Bauer J. M., et al. Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People // Age Ageing. 2010; 39 (4): 412-423. DOI: 10.1093/ageing/afq034.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cruz-Jentoft A. J., Bahat G., Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis // Age Ageing. 2019; 48 (1): 16-31. DOI: 10.1093/ageing/afy169.</mixed-citation><mixed-citation xml:lang="en">Cruz-Jentoft A. J., Bahat G., Bauer J. et al. Sarcopenia: revised European consensus on definition and diagnosis // Age Ageing. 2019; 48 (1): 16-31. DOI: 10.1093/ageing/afy169.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Curcio F., Ferro G., Basile C. Biomarkers in sarcopenia: A multifactorial approach // Rev Epidemiol Sante Publique. 2014; 62 (5): 305-314. DOI: 10.1016/j.respe.2014.09.002.</mixed-citation><mixed-citation xml:lang="en">Curcio F., Ferro G., Basile C. Biomarkers in sarcopenia: A multifactorial approach // Rev Epidemiol Sante Publique. 2014; 62 (5): 305-314. DOI: 10.1016/j.respe.2014.09.002.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Scharf G., Heineke J. Finding good biomarkers for sarcopenia // J Cachexia Sarcopenia Muscle. 2012; 3 (3): 145-148. DOI: 10.1007/s13539-012-0081-7.</mixed-citation><mixed-citation xml:lang="en">Scharf G., Heineke J. Finding good biomarkers for sarcopenia // J Cachexia Sarcopenia Muscle. 2012; 3 (3): 145-148. DOI: 10.1007/s13539-012-0081-7.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Peterson S. J., Braunschweig C. A. Prevalence of Sarcopenia and Associated Outcomes in the Clinical Setting // Nutr. Clin. Pract. 2016; 31 (1): 40-48. DOI: 10.1177/0884533615622537.</mixed-citation><mixed-citation xml:lang="en">Peterson S. J., Braunschweig C. A. Prevalence of Sarcopenia and Associated Outcomes in the Clinical Setting // Nutr. Clin. Pract. 2016; 31 (1): 40-48. DOI: 10.1177/0884533615622537.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kizilarslanoglu M. C., Kuyumcu M. E., Yesil Y., Halil M. Sarcopenia in critically ill patients // J Anesth. 2016; 30 (5): 884-890. DOI: 10.1007/s00540-016-2211-4.</mixed-citation><mixed-citation xml:lang="en">Kizilarslanoglu M. C., Kuyumcu M. E., Yesil Y., Halil M. Sarcopenia in critically ill patients // J Anesth. 2016; 30 (5): 884-890. DOI: 10.1007/s00540-016-2211-4.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Пасечник И. Н., Закревский А. И., Талызин П. А., Мазова М. С. Саркопения: взгляд анестезиолога-реаниматолога // Кремлевская медицина. Клинический вестник. 2021; 1: 82-89. DOI: 10.26269/zqkk-j843.</mixed-citation><mixed-citation xml:lang="en">Pasechnik I.N., Zakrevskiy A.I., Talyzin P.A., Mazova M.S. Sarcopenia: the view of an anesthesiologist-resuscitator.. Kremlevskaya meditsina. Klinicheskiy vestnik. 2021; 1: 82-89. Doi.: 10.26269/zqkk-j843</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Atkins J. L., Whincup P. H., Morris R. W. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men // J Am Geriatr Soc. 2014; 62 (2): 253-260. DOI: 10.1111/jgs.12652.</mixed-citation><mixed-citation xml:lang="en">Atkins J. L., Whincup P. H., Morris R. W. Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men // J Am Geriatr Soc. 2014; 62 (2): 253-260. DOI: 10.1111/jgs.12652.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Закревский А. И., Фёдорова А. А., Пасечник И. Н., Кутепов Д. Е. Саркопения: как её диагностировать? // Клиническое питание и метаболизм. 2021; 1 (2): 13-22. DOI: 10.17816/clinutr71107.</mixed-citation><mixed-citation xml:lang="en">Zakrevsky A. I., Fedorova A. A., Pasechnik I. N., Kutepov D. E. Sarcopenia: how to diagnose it? // Klinicheskoe pitanie i metabolizm. 2021; 1 (2): 13-22. DOI: 10.17816/clinutr71107.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Newman A. B., Kupelian V., Visser M. et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort // J Gerontol A Biol Sci Med Sci. 2006; 61 (1): 72-77. DOI: 10.1093/gerona/61.1.72.</mixed-citation><mixed-citation xml:lang="en">Newman A. B., Kupelian V., Visser M. et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort // J Gerontol A Biol Sci Med Sci. 2006; 61 (1): 72-77. DOI: 10.1093/gerona/61.1.72.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ticinesi A., Narici M. V., Lauretani F. Assessing sarcopenia with vastus lateralis muscle ultrasound: an operative protocol // Aging Clin Exp Res. 2018; 30 (12): 1437-1443. DOI: 10.1007/s40520-018-0958-1.</mixed-citation><mixed-citation xml:lang="en">Ticinesi A., Narici M. V., Lauretani F. Assessing sarcopenia with vastus lateralis muscle ultrasound: an operative protocol // Aging Clin Exp Res. 2018; 30 (12): 1437-1443. DOI: 10.1007/s40520-018-0958-1.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Montiel-Rojas D., Nilsson A., Santoro A. et al. Fighting Sarcopenia in Ageing European Adults: The Importance of the Amount and Source of Dietary Proteins // Nutrients. 2020; 12 (12): 3601. DOI: 10.3390/nu12123601.</mixed-citation><mixed-citation xml:lang="en">Montiel-Rojas D., Nilsson A., Santoro A. et al. Fighting Sarcopenia in Ageing European Adults: The Importance of the Amount and Source of Dietary Proteins // Nutrients. 2020; 12 (12): 3601. DOI: 10.3390/nu12123601.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">McKendry J., Thomas A. C. Q., Phillips S. M. Muscle Mass Loss in the Older Critically Ill Population: Potential Therapeutic Strategies // Nutr Clin Pract. 2020; 35 (4): 607-616. DOI: 10.1002/ncp.10540.</mixed-citation><mixed-citation xml:lang="en">McKendry J., Thomas A. C. Q., Phillips S. M. Muscle Mass Loss in the Older Critically Ill Population: Potential Therapeutic Strategies // Nutr Clin Pract. 2020; 35 (4): 607-616. DOI: 10.1002/ncp.10540.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Российские клинические рекомендации по проведению нутритивной поддержки у больных с острыми нарушениями мозгового кровообращения, 2013. https://rehabrus.ru/Docs/2020/protokol-nutritsii-pri-onmk-32.pdf.</mixed-citation><mixed-citation xml:lang="en">Russian clinical guidelines for nutritional support in patients with acute cerebrovascular accidents, 2013. https://rehabrus.ru/Docs/2020/protokol-nutritsii-pri-onmk-32.pdf</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Gariballa S. E., Parker S. G., Taub N., Castleden C. M. A randomized, controlled, a single-blind trial of nutritional supplementation after acute stroke // JPEN J Parenter Enteral Nutr. 1998; 22 (5): 315-319. DOI: 10.1177/0148607198022005315.</mixed-citation><mixed-citation xml:lang="en">Gariballa S. E., Parker S. G., Taub N., Castleden C. M. A randomized, controlled, a single-blind trial of nutritional supplementation after acute stroke // JPEN J Parenter Enteral Nutr. 1998; 22 (5): 315-319. DOI: 10.1177/0148607198022005315.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Gariballa S., Forster S., Walters S., Powers H. A randomized, double-blind, placebo-controlled trial of nutritional supplementation during acute illness // Am J Med. 2006; 119 (8): 693-699. DOI: 10.1016/j.amjmed.2005.12.006.</mixed-citation><mixed-citation xml:lang="en">Gariballa S., Forster S., Walters S., Powers H. A randomized, double-blind, placebo-controlled trial of nutritional supplementation during acute illness // Am J Med. 2006; 119 (8): 693-699. DOI: 10.1016/j.amjmed.2005.12.006.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Smith G. I., Atherton P., Reeds D. N., et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial // Am J Clin Nutr. 2011; 93 (2): 402-412. DOI: 10.3945/ajcn.110.005611.</mixed-citation><mixed-citation xml:lang="en">Smith G. I., Atherton P., Reeds D. N., et al. Dietary omega-3 fatty acid supplementation increases the rate of muscle protein synthesis in older adults: a randomized controlled trial // Am J Clin Nutr. 2011; 93 (2): 402-412. DOI: 10.3945/ajcn.110.005611.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Smith G. I., Julliand S., Reeds D. N., Sinacore D. R., Klein S., Mittendorfer B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults // Am J Clin Nutr. 2015; 102 (1): 115-22. DOI: 10.3945/ajcn.114.105833.</mixed-citation><mixed-citation xml:lang="en">Smith G. I., Julliand S., Reeds D. N., Sinacore D. R., Klein S., Mittendorfer B. Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults // Am J Clin Nutr. 2015; 102 (1): 115-22. DOI: 10.3945/ajcn.114.105833.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
